Global Leigh Syndrome Treatment Market is Estimated to Witness High Growth Owing to Advancement in Gene Therapy

The global Leigh syndrome treatment market is witnessing high growth owing to the advancement in gene therapy. Leigh syndrome is a rare neurological genetic disorder that affects the central nervous system and metabolism. It is usually seen in infants and children under the age of 2. The signs and symptoms associated with Leigh syndrome include poor muscle tone, muscle weakness, vision issues, lack of coordination, impaired gait, breathing difficulties, and organ dysfunction. The treatment options are mainly focused on symptom management through physical therapy, medications, surgical intervention, and oxygen therapy. However, gene therapy offers promising results for treating the underlying cause of the disease.
The Global Leigh syndrome treatment market is estimated to be valued at US$ 272.9 MN in 2024 and is expected to exhibit a CAGR of 6.7% over the forecast period 2024 to 2031.

https://cmiresearch.blogspot.c....om/2024/04/the-growi